Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (41-50 of 401) with videos related to

Pageof 41
Sort By:
European Heart Journal|March 13, 2019
Combining DAPT with a PPI faces the acid test of real-world useWilliam A E Parker, Robert F Storey
British Journal of Pharmacology|September 29, 2023
The role of platelet P2Y<sub>12</sub> receptors in inflammationWilliam A E Parker, Robert F Storey
European Heart Journal|November 17, 2024
Oral anticoagulation and non-steroidal anti-inflammatory drugs: a recipe for bleedingWilliam A E Parker, Robert F Storey
European Heart Journal|December 20, 2015
Choosing a perspective on mortality with DAPTWilliam A E Parker, Robert F Storey
Platelets|January 21, 2020
Novel approaches to P2Y<sub>12</sub> inhibition and aspirin dosingWilliam A E Parker, Robert F Storey
Thrombosis and Haemostasis|April 12, 2011
Update on lipids, inflammation and atherothrombosisLina Badimon, Robert F Storey, Gemma Vilahur
European Heart Journal|September 4, 2021
Ticagrelor monotherapy in CKD: better safety at what price?William A E Parker, Robert F Storey
Cardiovascular Research|August 9, 2021
Aspirin dosing for atherosclerotic cardiovascular disease: should we be more ADAPTABLE?William A E Parker, Robert F Storey
European Heart Journal|March 4, 2026
Direct-acting oral anticoagulant or vitamin K antagonist for the frail elderly patient with atrial fibrillation: does one size fit all?William A E Parker, Robert F Storey
Current Pharmaceutical Design|June 26, 2012
Platelet function testing in atherothrombotic diseaseErik Lerkevang Grove, Robert F Storey, Morten Würtz
Pageof 41

Showing results (41-50 of 401) with videos related to

Sort By:
Pageof 41
European Heart Journal|March 13, 2019
Combining DAPT with a PPI faces the acid test of real-world useWilliam A E Parker, Robert F Storey
British Journal of Pharmacology|September 29, 2023
The role of platelet P2Y<sub>12</sub> receptors in inflammationWilliam A E Parker, Robert F Storey
European Heart Journal|November 17, 2024
Oral anticoagulation and non-steroidal anti-inflammatory drugs: a recipe for bleedingWilliam A E Parker, Robert F Storey
European Heart Journal|December 20, 2015
Choosing a perspective on mortality with DAPTWilliam A E Parker, Robert F Storey
Platelets|January 21, 2020
Novel approaches to P2Y<sub>12</sub> inhibition and aspirin dosingWilliam A E Parker, Robert F Storey
Thrombosis and Haemostasis|April 12, 2011
Update on lipids, inflammation and atherothrombosisLina Badimon, Robert F Storey, Gemma Vilahur
European Heart Journal|September 4, 2021
Ticagrelor monotherapy in CKD: better safety at what price?William A E Parker, Robert F Storey
Cardiovascular Research|August 9, 2021
Aspirin dosing for atherosclerotic cardiovascular disease: should we be more ADAPTABLE?William A E Parker, Robert F Storey
European Heart Journal|March 4, 2026
Direct-acting oral anticoagulant or vitamin K antagonist for the frail elderly patient with atrial fibrillation: does one size fit all?William A E Parker, Robert F Storey
Current Pharmaceutical Design|June 26, 2012
Platelet function testing in atherothrombotic diseaseErik Lerkevang Grove, Robert F Storey, Morten Würtz
Pageof 41